Navigation Links
GPhA Announces 2008-2009 Executive Committee; Teva North America's Bill Marth Elected as Chairman of the Board
Date:2/12/2008

BOCA RATON, Fla., Feb. 12 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) Board of Directors today named the members of its newly elected Executive Committee and announced the election of William Marth, President and CEO of Teva North America, to serve as its Chairman for 2008- 2009.

Mr. Marth has 30 years of experience in the pharmaceutical industry, including nearly a decade with Teva, which is among the top 20 pharmaceutical companies in the world and is the leading generic pharmaceutical company. Mr. Marth has served on GPhA's Board of Directors since 2005, most recently as Vice Chair.

"We are very pleased to welcome Bill as GPhA's Chairman of the Board," said Kathleen Jaeger, GPhA President and CEO. "2008 will be an extremely busy year and we look forward to Bill's excellent leadership as we work to increase consumer access to safe, affordable generic medicines.

"We also would like to extend our heartfelt thanks to Bruce Downey for his two years of outstanding service as chairman and for his dedication to the industry."

The GPhA Board also elected Hal Korman, President, North America, Mylan Inc., as its Vice Chairman and re-elected Rosendo Ferran, Senior Consultant, New Chemic, Inc., to serve as its Secretary-Treasurer. Bernhard Hampl, President and CEO, Sandoz US, and Bruce Downey, Chairman and CEO, Barr Pharmaceuticals Inc., will serve as at-large members on the Board's Executive Committee.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Unbranded and branded generics represent 65% of the total prescriptions dispensed in the United States, but only 20% of all dollars spent on prescription drugs. For more information about the industry, visit http://www.gphaonline.org.
'/>"/>

SOURCE Generic Pharmaceutical Association (GPhA)
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 iTanSmart is ... and iPads. The app provides a tailored approach to ... potentially dangerous sunburns and skin damage. In his review, ... sounds, and capabilities of iTanSmart. , Eaton begins ... app as a ‘better organized’ and ‘great alternative’ to ...
(Date:7/25/2014)... According to the Liver Cirrhosis ... Vkool.com, this is a comprehensive guide that provides ... safe remedies for liver cirrhosis . This ...     Chapter 1: Liver Cirrhosis Bible & ... About Liver Basics ,     Chapter 3: Getting ...
(Date:7/25/2014)... July 25, 2014 At World T.E.A.M. ... July 19, 17 participating developmentally-disabled teens and young adults ... if off-road bicycling, canoeing and hiking can be challenging. ... at the scenic Chesapeake and Ohio Canal National ... athletes both disabled and able-bodied. Under slightly overcast skies ...
(Date:7/24/2014)... 2014 Dr. Henry H. Ting, a ... has been appointed senior vice president and chief quality ... his new role, he will oversee the hospital's clinical ... successfully led quality initiatives and interprofessional teams at the ... for the Door-to-Balloon Alliance, a collaboration of more than ...
(Date:7/24/2014)... bearing human breast tumors, exposure to dim light at ... drug tamoxifen, according to data published in Cancer ... Cancer Research. The negative effects of dim light exposure ... melatonin supplement during the night. , "Resistance to tamoxifen ... breast cancer," said Steven M. Hill, PhD, professor of ...
Breaking Medicine News(10 mins):Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 2Health News:Liver Cirrhosis Bible & Ezra Protocol Review Exposes Debra Elkin's Liver Cirrhosis Treatment Guide – Vkool - Better Information, Better Lives 3Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 2Health News:DC Adventure Team Challenge Thrills Developmentally-Disabled Participants 3Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 2Health News:NewYork-Presbyterian Hospital Names New Senior Vice President for Quality and Patient Safety 3Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Nov. ... known as "K2" is sending young people to the ... toxicologists warn. In recent months, physicians and toxicologists ... emergency rooms after smoking synthetic marijuana. Despite the side ...
... calculations in the supercomputer MareNostrum at the Barcelona Supercomputing ... for Research in Biomedicine (IRB Barcelona) have presented the ... this new database holds more than 1,700 proteins and ... has been developed to study the basic biology of ...
... Nov. 11 (HealthDay News) -- Long-term use of vitamin E ... in men, a new study finds. "An estimated 20.5 ... some evidence of age-related cataract," wrote study author William G. ... in Boston, and colleagues, in a news release. Because ...
... , THURSDAY, Nov. 11 (HealthDay News) -- Many U.S. ... dinner, meals that provide nutrients critical to youngsters, development, ... The American Dietetic Association Foundation poll of 1,193 ... found that breakfast is sometimes missed by 42 percent ...
... American Society of Nephrology (ASN) proudly highlight the ... The Halpin Foundation-ASN Research Grant, created to help ... provides recipients transition funding toward successful application for ... (McGill University Faculty of Medicine), the 2008 recipient ...
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, ... depicting emaciated lung cancer patients, a dead body in a ... of secondhand smoke) and other consequences of smoking that will ... people into quitting the habit or not starting in the ...
Cached Medicine News:Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 2Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 3Health News:Scientists at IRB Barcelona and BSC publish the world's largest video data bank of proteins 2Health News:Study Finds Vitamins E and C Don't Reduce Cataract Risk in Men 2Health News:Many Kids Skipping Meals, Snacking Instead 2Health News:Putting the spotlight on membranous nephropathy 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 2Health News:FDA Proposes Graphic Warnings on Cigarette Packs 3
(Date:7/24/2014)... Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty ... for the second quarter ended June 30, 2014. ... $6.5 million in the second quarter of 2014, an increase ... Total revenues of $13.3 million for the six months ended ... period in 2013 , Total revenues generated from the ...
(Date:7/24/2014)... ATLANTA , July 24, 2014  Alimera Sciences, ... company that specializes in the research, development and commercialization ... release its second quarter of fiscal year 2014 financial ... 2014. An investor conference call will follow on the ... The conference call will be hosted by Dan ...
(Date:7/24/2014)... BUFFALO, N.Y. , July 24, 2014  Kinex ... US FDA for the Company,s KX2-391 Ointment for the ... keratosis. This is the Company,s third IND to be ... months. KX2-391 is a synthetic, orally active ... and tubulin polymerization. KX2-391 promotes the induction of p53, ...
Breaking Medicine Technology:IGI Laboratories Announces Second Quarter 2014 Results 2IGI Laboratories Announces Second Quarter 2014 Results 3IGI Laboratories Announces Second Quarter 2014 Results 4IGI Laboratories Announces Second Quarter 2014 Results 5IGI Laboratories Announces Second Quarter 2014 Results 6IGI Laboratories Announces Second Quarter 2014 Results 7Alimera Sciences To Release Second Quarter 2014 Results 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4
... Asthmatx, Inc. presented the results of a series ... thermoplasty delivered by the Alair® System, and how this ... in a poster at the 2009 Annual Meeting of ... in Miami Beach, Fla. , The poster, titled "Where ...
... PALO ALTO, Calif., Nov. 9 Women,s sexual health company, ... as it prepares for a 2010 launch of its Viveve ... a name that we believe captures the essence of our ... president and chief executive. "Viveve exists for the sole purpose ...
Cached Medicine Technology:Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 2Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting 3Women's Sexual Health Company Changes Name in Preparation for Market Entry 2
... is a basic laboratory system for pH ... can be obtained when used with a ... • Fast and easy one and two-point ... five buffers (pH 1.68, 4.00, 7.00, 10.01 ...
... Multimode Detectors provide unmatched value and ... and automation needs. Capable of performing ... the same instrument, the DTX Series ... can be integrated seamlessly with Beckman ...
... is a dual-monochromator, multi-detection microplate reader ... 6-384 microplate reading capability. Detection modalities ... intensity (FI) and have optical performance ... or spectrophotometer. Endpoint, kinetic, spectrum and ...
... microplate reader combines improved flexibility ... with a wide range of ... the flexibility, sensitivity and high ... is the ideal detection solution ...
Medicine Products: